Language
National
International
Analysis
Opinion
Business
Personal Finance
Sports
Technology
Lifestyle
Entertainment
Language
National
International
Analysis
Opinion
Business
Personal Finance
Sports
Technology
Lifestyle
Entertainment
Authors
{{#static_pages}}
{{ name }}
{{/static_pages}}
You have successfully subscribed the newsletter.
Advertisment
Biocon Biologics
Eris acquires commercial rights of Biocon Biologics' India branded formulations biz for Rs 1,242 cr
Eris Lifesciences on Thursday said it has acquired commercial rights of Biocon Biologics' India branded formulation business for Rs 1,242 crore.The acquisition...
Biocon Biologics settles patent issue; paves way for launch of biosimilar product in Canada
Serum to pump in additional USD 150 mn in Biocon Biologics
USFDA issues CRL for proposed biosimilar Insulin-R: Biocon
Biocon Biologics elevates Shreehas Tambe as MD & CEO
Subscribe to our Newsletter!
Be the first to get exclusive offers and the latest news
Subscribe Now
Advertisment
Subscribe
Select Language
English
Hindi
Share this article
If you liked this article share it with your friends.
they will thank you later
Facebook
Twitter
Whatsapp
Copied!